Disease Flares Among Early Rheumatoid Arthritis Patients Treated with Continued Methotrexate Either Alone or in Combination with Adalimumab (Humira)

被引：0

作者：

Kavanaugh, Arthur ^{[1
]}

van Vollenhoven, Ronald F. ^{[2
]}

Sunkureddi, Prashanth ^{[3
]}

Zhang, Ying ^{[4
]}

Suboticki, Jessica L. ^{[5
]}

Smolen, Josef S. ^{[6
,7
]}

机构：

[1] Univ Calif San Diego, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA

[2] Amsterdam Rheumatol & Immunol Ctr ARC, Amsterdam, Netherlands

[3] Univ Texas Med Branch, Galveston, TX 77555 USA

[4] AbbVie Inc, N Chicago, IL USA

[5] AbbVie Inc, Mettawa, IL USA

[6] Med Univ Vienna, Dept Med, Div Rheumatol, Vienna, Austria

[7] Hietzing Hosp, Vienna, Austria

来源：

ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2456

引用

页数：2

共 50 条

[31] The efficacy and safety of Adalimunab (Humira®) plus Methotrexate vs. Adalimumab alone or methotrexate alone in the early treatment of rheumatoid arthritis (RA):: 1-and 2-year results of the premier study
Breedveld, FC
Weisman, MH
Kavanaugh, AF
Cohen, SB
Pavelka, K
Van Vollenhoven, R
Perez, JL
Spencer-Green, GT
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 60 - 60
[32] In early rheumatoid arthritis combination therapy with methotrexate and infliximab is more efficacious than methotrexate alone
St Clair, EW
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (03) : 289 - 290
[33] The combination glucocorticoid-adalimumab-methotrexate as induction therapy in early aggressive rheumatoid arthritis
Montecucco, Carlomaurizio
Caporali, Roberto
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (05) : 829 - 829
[34] Adalimumab (HUMIRA®) plus methotrexate is safe and efficacious in patients with rheumatoid arthritis into the 7th year of therapy
Schiff, MH
Breedveld, FC
Weisman, MH
Rau, R
Weinblatt, ME
Kupper, H
Spencer-Green, GT
Segurado, OG
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 438 - +
[35] Adalimumab (HUMIRA®) plus methotrexate induces sustained remission in both early and long-standing rheumatoid arthritis.
Emery, P
Schiff, MH
Kalden, JR
Spencer-Green, GT
Segurado, OG
ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S183 - S184
[36] Significant clinical improvements at 6 months are sustained over 4 years in patients with rheumatoid arthritis treated with adalimumab (HUMIRA®) plus methotrexate.
Schiff, MH
Weisman, MH
Cohen, SB
Kavanaugh, AF
Spencer-Green, GT
Perez, JL
Mydler, TT
Segurado, OG
ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S182 - S183
[37] Long-term remission, efficacy and safety in patients with rheumatoid arthritis treated with adalimumab (Humira®) plus methotrexate for more than 5 years
Breedveld, FC
Rau, R
Van Riel, P
van de Putte, L
Schattenkirchner, M
Kupper, H
Segurado, O
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 268 - 268
[38] Methotrexate Dose Has Minimal Effects On Methotrexate-Related Toxicity In Patients With Early Rheumatoid Arthritis Treated In Combination With Adalimumab - Results Of Concerto Trial.
Burmester, Gerd R.
Kivitz, Alan J.
van Vollenhoven, Ronald F.
Florentinus, Stefan
Karunaratne, Piyalal M.
Kupper, Hartmut
Dougados, Maxime
Fleischmann, Roy M.
ARTHRITIS AND RHEUMATISM, 2013, 65 : S1148 - S1149
[39] The PREMIER study - A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
Breedveld, FC
Weisman, MH
Kavanaugh, AF
Cohen, SB
Pavelka, K
van Vollenhoven, R
Sharp, J
Perez, JL
Spencer-Green, GT
ARTHRITIS AND RHEUMATISM, 2006, 54 (01): : 26 - 37
[40] Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate
Cohen, Stanley B.
Keystone, Edward
Genovese, Mark C.
Emery, Paul
Peterfy, Charles
Tak, Paul Peter
Cravets, Matt
Shaw, Tim
Hagerty, David
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (06) : 1158 - 1161

← 1 2 3 4 5 →